---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-381076"
form_type: "8-K"
ticker: "LBRX"
cik: "0001691082"
company_name: "LB PHARMACEUTICALS INC"
filed_at: "2026-09-03T12:05:06+00:00"
generated_at: "2026-09-03T12:10:07.352202+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# LB Pharmaceuticals appoints Joseph Miller as CFO, effective September 2, 2026

## Summary
- Joseph M. Miller named CFO; previously CFO of Aurinia Pharmaceuticals (April 2020–March 2026).
- Initial annual base salary of $530,000; target bonus of 40% of base salary.
- Inducement option for 200,000 shares vesting over 4 years, 25% on first anniversary.
- Company nears NOVA-2 clinical trial readout and prepares for potential LB-102 launch in schizophrenia.

## SEC filing metadata
- accession: 0001193125-26-381076
- form_type: 8-K
- ticker: LBRX
- cik: 0001691082
- company_name: LB PHARMACEUTICALS INC
- filed_at: 2026-09-03T12:05:06+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1691082/000119312526381076/0001193125-26-381076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1691082/000119312526381076/d26110d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-381076
- JSON: https://secwatch.observer/filing/0001193125-26-381076.json
- Plain text: https://secwatch.observer/filing/0001193125-26-381076.txt

## Key facts
- Executive change
  Joseph M. Miller was appointed as Chief Financial Officer at LB PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On September 3, 2026, LB Pharmaceuticals Inc (the “Company”) announced that Joseph M. Miller has been appointed to serve as the Company’s Chief Financial Officer, effective as of September 2, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/1691082/000119312526381076/0001193125-26-381076-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.